mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck sayAugust 19, 2026 2026-08-19 07:53 GMT · 3 days ago aimagpro.com vendor source link The vaccine reportedly thwarted the cancer’s return and spread.